{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:35:14Z","timestamp":1790771714496,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Changsha","award":["kq2208340"],"award-info":[{"award-number":["kq2208340"]}]},{"name":"the Hunan Administration of Traditional Chinese Medicine","award":["D2022109"],"award-info":[{"award-number":["D2022109"]}]},{"name":"the Scientific Research Program of Hunan Provincial Health Commission","award":["D202303106778"],"award-info":[{"award-number":["D202303106778"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ5494"],"award-info":[{"award-number":["2024JJ5494"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2024JJ9203"],"award-info":[{"award-number":["2024JJ9203"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hunan Innovative Province Construction Special Project","award":["2021ZK4025"],"award-info":[{"award-number":["2021ZK4025"]}]},{"name":"Hunan Provincial Development and Reform Commission of Innovative Research Program","award":["2021-212-23"],"award-info":[{"award-number":["2021-212-23"]}]},{"name":"the Hunan Provincial Department of Finance Gra","award":["2022-151"],"award-info":[{"award-number":["2022-151"]}]},{"name":"the Hunan Provincial Department of Finance Gra","award":["2021-139"],"award-info":[{"award-number":["2021-139"]}]},{"name":"the Hunan Provincial Department of Finance Gra","award":["2020-83"],"award-info":[{"award-number":["2020-83"]}]},{"name":"the Hunan Provincial Department of Finance Gra","award":["2019-93"],"award-info":[{"award-number":["2019-93"]}]},{"name":"the Hunan Provincial Department of Finance Gra","award":["2018-92"],"award-info":[{"award-number":["2018-92"]}]},{"name":"the China National Key R&D Program","award":["Nos2020YFC2009000"],"award-info":[{"award-number":["Nos2020YFC2009000"]}]},{"name":"the China National Key R&D Program","award":["2020YFC2009001"],"award-info":[{"award-number":["2020YFC2009001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10557-025-07683-4","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T11:34:52Z","timestamp":1742470492000},"page":"347-359","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Effect of Verapamil on Blood Glucose in Type 1 and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Shiqi","family":"Tu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyue","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaokai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0126-4978","authenticated-orcid":false,"given":"Qiong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"7683_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-022-00762-8","volume":"19","author":"J Kaur","year":"2023","unstructured":"Kaur J, Seaquist ER. Hypoglycaemia in type 1 diabetes mellitus: risks and practical prevention strategies. Nat Rev Endocrinol. 2023;19:177\u201386. https:\/\/doi.org\/10.1038\/s41574-022-00762-8","journal-title":"Nat Rev Endocrinol"},{"key":"7683_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1210\/er.2007-0002","volume":"28","author":"SE Fineberg","year":"2007","unstructured":"Fineberg SE, Kawabata TT, Finco-Kent D, Fountaine RJ, Finch GL, Krasner AS. Immunological responses to exogenous insulin. Endocr Rev. 2007;28:625\u201352. https:\/\/doi.org\/10.1210\/er.2007-0002","journal-title":"Endocr Rev"},{"key":"7683_CR3","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.2174\/1381612821666150710145753","volume":"21","author":"MJ Meneses","year":"2015","unstructured":"Meneses MJ, Silva BM, Sousa M, Sa R, Oliveira PF, Alves MG. Antidiabetic drugs: mechanisms of action and potential outcomes on cellular metabolism. Curr Pharm Des. 2015;21:3606\u201320. https:\/\/doi.org\/10.2174\/1381612821666150710145753","journal-title":"Curr Pharm Des"},{"key":"7683_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1001\/jama.2024.1137","volume":"331","author":"CC Thomas","year":"2024","unstructured":"Thomas CC, Chopra K, Davis AM. Management of outpatients with diabetes at high risk of hypoglycemia. JAMA. 2024;331:1145\u20136. https:\/\/doi.org\/10.1001\/jama.2024.1137","journal-title":"JAMA"},{"key":"7683_CR5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1210\/clinem\/dgaa863","volume":"106","author":"MK Thomas","year":"2021","unstructured":"Thomas MK, Nikooienejad A, Bray R, et al. Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes. J Clin Endocrinol Metab. 2021;106:388\u201396. https:\/\/doi.org\/10.1210\/clinem\/dgaa863","journal-title":"J Clin Endocrinol Metab"},{"key":"7683_CR6","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/biomedicines11030807","volume":"11","author":"K Zhao","year":"2023","unstructured":"Zhao K, Shi Y, Yu J, et al. In vivo Ca(V)3 channel inhibition promotes maturation of glucose-dependent Ca(2+) signaling in human iPSC-islets. Biomedicines. 2023;11:807. https:\/\/doi.org\/10.3390\/biomedicines11030807","journal-title":"Biomedicines"},{"key":"7683_CR7","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.jmb.2019.08.014","volume":"432","author":"DA Jacobson","year":"2020","unstructured":"Jacobson DA, Shyng SL. Ion channels of the islets in type 2 diabetes. J Mol Biol. 2020;432:1326\u201346. https:\/\/doi.org\/10.1016\/j.jmb.2019.08.014","journal-title":"J Mol Biol"},{"key":"7683_CR8","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.2337\/db15-1718","volume":"65","author":"C Chen","year":"2016","unstructured":"Chen C, Chmelova H, Cohrs CM, et al. Alterations in \u03b2-cell calcium dynamics and efficacy outweigh islet mass adaptation in compensation of insulin resistance and prediabetes onset. Diabetes. 2016;65:2676\u201385. https:\/\/doi.org\/10.2337\/db15-1718","journal-title":"Diabetes"},{"key":"7683_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","volume":"24","author":"F Ovalle","year":"2018","unstructured":"Ovalle F, Grimes T, Xu G, et al. Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat Med. 2018;24:1108\u201312. https:\/\/doi.org\/10.1038\/s41591-018-0089-4","journal-title":"Nat Med"},{"key":"7683_CR10","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.2337\/db19-0813","volume":"69","author":"J Vogel","year":"2020","unstructured":"Vogel J, Yin J, Su L, et al. A phenotypic screen identifies calcium overload as a key mechanism of \u03b2-cell glucolipotoxicity. Diabetes. 2020;69:1032\u201341. https:\/\/doi.org\/10.2337\/db19-0813","journal-title":"Diabetes"},{"key":"7683_CR11","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.2337\/db23-0256","volume":"72","author":"G Xu","year":"2023","unstructured":"Xu G, Chen J, Lu B, Sethupathy P, Qian WJ, Shalev A. Verapamil prevents decline of IGF-I in subjects with type 1 diabetes and promotes \u03b2-cell IGF-I signaling. Diabetes. 2023;72:1460\u20139. https:\/\/doi.org\/10.2337\/db23-0256","journal-title":"Diabetes"},{"key":"7683_CR12","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41467-022-28360-2","volume":"13","author":"F D'Addio","year":"2022","unstructured":"D\u2019Addio F, Maestroni A, Assi E, et al. The IGFBP3\/TMEM219 pathway regulates beta cell homeostasis. Nat Commun. 2022;13:684. https:\/\/doi.org\/10.1038\/s41467-022-28360-2","journal-title":"Nat Commun"},{"key":"7683_CR13","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1016\/j.ymthe.2020.07.016","volume":"28","author":"X Li","year":"2020","unstructured":"Li X, Wu Y, Song Y, et al. Activation of NF-\u03baB-inducing kinase in islet \u03b2 cells causes \u03b2 cell failure and diabetes. Mol Ther. 2020;28:2430\u201341. https:\/\/doi.org\/10.1016\/j.ymthe.2020.07.016","journal-title":"Mol Ther"},{"key":"7683_CR14","doi-asserted-by":"publisher","first-page":"F1","DOI":"10.1530\/jme-16-0183","volume":"61","author":"K Meyerovich","year":"2018","unstructured":"Meyerovich K, Ortis F, Cardozo AK. The non-canonical NF-\u03baB pathway and its contribution to \u03b2-cell failure in diabetes. J Mol Endocrinol. 2018;61:F1-f6. https:\/\/doi.org\/10.1530\/jme-16-0183","journal-title":"J Mol Endocrinol"},{"key":"7683_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/dmso.S232221","volume":"13","author":"DZ Wondafrash","year":"2020","unstructured":"Wondafrash DZ, Nire\u2019a AT, Tafere GG, Desta DM, Berhe DA, Zewdie KA. Thioredoxin-interacting protein as a novel potential therapeutic target in diabetes mellitus and its underlying complications. Diabetes Metab Syndr Obes. 2020;13:43\u201351. https:\/\/doi.org\/10.2147\/dmso.S232221","journal-title":"Diabetes Metab Syndr Obes"},{"key":"7683_CR16","doi-asserted-by":"publisher","first-page":"153741","DOI":"10.1016\/j.phymed.2021.153741","volume":"93","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Aisker G, Dong H, Halemahebai G, Zhang Y, Tian L. Urolithin A suppresses glucolipotoxicity-induced ER stress and TXNIP\/NLRP3\/IL-1\u03b2 inflammation signal in pancreatic \u03b2 cells by regulating AMPK and autophagy. Phytomedicine. 2021;93:153741. https:\/\/doi.org\/10.1016\/j.phymed.2021.153741","journal-title":"Phytomedicine"},{"key":"7683_CR17","doi-asserted-by":"publisher","first-page":"848","DOI":"10.2337\/db11-0955","volume":"61","author":"G Xu","year":"2012","unstructured":"Xu G, Chen J, Jing G, Shalev A. Preventing \u03b2-cell loss and diabetes with calcium channel blockers. Diabetes. 2012;61:848\u201356. https:\/\/doi.org\/10.2337\/db11-0955","journal-title":"Diabetes"},{"key":"7683_CR18","doi-asserted-by":"publisher","first-page":"174061","DOI":"10.1016\/j.ejphar.2021.174061","volume":"901","author":"LD Eissa","year":"2021","unstructured":"Eissa LD, Ghobashy WA, El-Azab MF. Inhibition of thioredoxin-interacting protein and inflammasome assembly using verapamil mitigates diabetic retinopathy and pancreatic injury. Eur J Pharmacol. 2021;901:174061. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174061","journal-title":"Eur J Pharmacol"},{"key":"7683_CR19","doi-asserted-by":"publisher","first-page":"243","DOI":"10.15386\/mpr-2187","volume":"95","author":"AM Borowiec","year":"2022","unstructured":"Borowiec AM, W\u0142aszczuk A, Olakowska E, Lewin-Kowalik J. TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients. Med Pharm Rep. 2022;95:243\u201350. https:\/\/doi.org\/10.15386\/mpr-2187","journal-title":"Med Pharm Rep"},{"key":"7683_CR20","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.molcel.2013.01.035","volume":"49","author":"N Wu","year":"2013","unstructured":"Wu N, Zheng B, Shaywitz A, et al. AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1. Mol Cell. 2013;49:1167\u201375. https:\/\/doi.org\/10.1016\/j.molcel.2013.01.035","journal-title":"Mol Cell"},{"key":"7683_CR21","doi-asserted-by":"publisher","first-page":"6110","DOI":"10.3390\/ijms20246110","volume":"20","author":"C Klec","year":"2019","unstructured":"Klec C, Ziomek G, Pichler M, Malli R, Graier WF. Calcium signaling in \u00df-cell physiology and pathology: a revisit. Int J Mol Sci. 2019;20:6110. https:\/\/doi.org\/10.3390\/ijms20246110","journal-title":"Int J Mol Sci"},{"key":"7683_CR22","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/s1734-1140(09)70111-2","volume":"61","author":"S Patel","year":"2009","unstructured":"Patel S, Santani D. Role of NF-kappa B in the pathogenesis of diabetes and its associated complications. Pharmacol Rep. 2009;61:595\u2013603. https:\/\/doi.org\/10.1016\/s1734-1140(09)70111-2","journal-title":"Pharmacol Rep"},{"key":"7683_CR23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.semcdb.2022.09.004","volume":"154","author":"S Klimczak","year":"2024","unstructured":"Klimczak S, \u015aliwi\u0144ska A. Epigenetic regulation of inflammation in insulin resistance. Semin Cell Dev Biol. 2024;154:185\u201392. https:\/\/doi.org\/10.1016\/j.semcdb.2022.09.004","journal-title":"Semin Cell Dev Biol"},{"key":"7683_CR24","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.diabres.2016.01.021","volume":"115","author":"Y Khodneva","year":"2016","unstructured":"Khodneva Y, Shalev A, Frank SJ, Carson AP, Safford MM. Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study. Diabetes Res Clin Pract. 2016;115:115\u201321. https:\/\/doi.org\/10.1016\/j.diabres.2016.01.021","journal-title":"Diabetes Res Clin Pract"},{"key":"7683_CR25","doi-asserted-by":"publisher","first-page":"e0255405","DOI":"10.1371\/journal.pone.0255405","volume":"16","author":"YS Chen","year":"2021","unstructured":"Chen YS, Weng SJ, Chang SH, et al. Evaluating the antidiabetic effects of R-verapamil in type 1 and type 2 diabetes mellitus mouse models. PLoS ONE. 2021;16:e0255405. https:\/\/doi.org\/10.1371\/journal.pone.0255405","journal-title":"PLoS ONE"},{"key":"7683_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/pharmaceutics12050468","volume":"12","author":"SY Han","year":"2020","unstructured":"Han SY, Choi YH. Pharmacokinetic interaction between metformin and verapamil in rats: inhibition of the OCT2-mediated renal excretion of metformin by verapamil. Pharmaceutics. 2020;12:468. https:\/\/doi.org\/10.3390\/pharmaceutics12050468","journal-title":"Pharmaceutics"},{"key":"7683_CR27","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1038\/s41467-024-47959-1","volume":"15","author":"Q Jiang","year":"2024","unstructured":"Jiang Q, Zhao Q, Chen Y, et al. Galectin-3 impairs calcium transients and \u03b2-cell function. Nat Commun. 2024;15:3682. https:\/\/doi.org\/10.1038\/s41467-024-47959-1","journal-title":"Nat Commun"},{"key":"7683_CR28","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1210\/en.2013-1519","volume":"155","author":"T Hara","year":"2014","unstructured":"Hara T, Mahadevan J, Kanekura K, Hara M, Lu S, Urano F. Calcium efflux from the endoplasmic reticulum leads to beta-cell death. Endocrinology. 2014;155:758\u201368. https:\/\/doi.org\/10.1210\/en.2013-1519","journal-title":"Endocrinology"},{"key":"7683_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.4103\/njcp.njcp_805_23","volume":"27","author":"E Alharbi","year":"2024","unstructured":"Alharbi E, Abanmy N, Mullen A, ElAbd S, Makhzoum Z, Alzahrani S. Effect of verapamil on glycemic control in type 2 diabetic hypertensive patients in Saudi Arabia: a quasi experimental study. Niger J Clin Pract. 2024;27:965\u201371. https:\/\/doi.org\/10.4103\/njcp.njcp_805_23","journal-title":"Niger J Clin Pract"},{"key":"7683_CR30","doi-asserted-by":"publisher","first-page":"e4063","DOI":"10.1210\/clinem\/dgac436","volume":"107","author":"CY Wang","year":"2022","unstructured":"Wang CY, Huang KC, Lu CW, et al. A randomized controlled trial of R-form verapamil added to ongoing metformin therapy in patients with type 2 diabetes. J Clin Endocrinol Metab. 2022;107:e4063\u201371. https:\/\/doi.org\/10.1210\/clinem\/dgac436","journal-title":"J Clin Endocrinol Metab"},{"key":"7683_CR31","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1007\/s13300-021-01145-4","volume":"12","author":"A Malayeri","year":"2021","unstructured":"Malayeri A, Zakerkish M, Ramesh F, Galehdari H, Hemmati AA, Angali KA. The effect of verapamil on TXNIP gene expression, GLP1R mRNA, FBS, HbA1c, and lipid profile in T2DM patients receiving metformin and sitagliptin. Diabetes Ther. 2021;12:2701\u201313. https:\/\/doi.org\/10.1007\/s13300-021-01145-4","journal-title":"Diabetes Ther"},{"key":"7683_CR32","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s0895-7061(03)00062-1","volume":"16","author":"H Holzgreve","year":"2003","unstructured":"Holzgreve H, Nakov R, Beck K, Janka HU. Antihypertensive therapy with verapamil SR plus trandolapril versus atenolol plus chlorthalidone on glycemic control. Am J Hypertens. 2003;16:381\u20136. https:\/\/doi.org\/10.1016\/s0895-7061(03)00062-1","journal-title":"Am J Hypertens"},{"key":"7683_CR33","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/sj.jhh.1001279","volume":"15","author":"R Fern\u00e1ndez","year":"2001","unstructured":"Fern\u00e1ndez R, Puig JG, Rodr\u00edguez-P\u00e9rez JC, Garrido J, Redon J. Effect of two antihypertensive combinations on metabolic control in type-2 diabetic hypertensive patients with albuminuria: a randomised, double-blind study. J Hum Hypertens. 2001;15:849\u201356. https:\/\/doi.org\/10.1038\/sj.jhh.1001279","journal-title":"J Hum Hypertens"},{"key":"7683_CR34","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1001\/jama.2023.2064","volume":"329","author":"GP Forlenza","year":"2023","unstructured":"Forlenza GP, McVean J, Beck RW, et al. Effect of verapamil on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial. JAMA. 2023;329:990\u20139. https:\/\/doi.org\/10.1001\/jama.2023.2064","journal-title":"JAMA"},{"key":"7683_CR35","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.2337\/dc06-1373","volume":"29","author":"G Bakris","year":"2006","unstructured":"Bakris G, Molitch M, Hewkin A, et al. Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome. Diabetes Care. 2006;29:2592\u20137. https:\/\/doi.org\/10.2337\/dc06-1373","journal-title":"Diabetes Care"},{"key":"7683_CR36","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.2337\/diacare.27.7.1688","volume":"27","author":"AF Rubio-Guerra","year":"2004","unstructured":"Rubio-Guerra AF, Arceo-Navarro A, Vargas-Ayala G, Rodriguez-Lopez L, Lozano-Nuevo JJ, Gomez-Harper CT. The effect of trandolapril and its fixed-dose combination with verapamil on proteinuria in normotensive adults with type 2 diabetes. Diabetes Care. 2004;27:1688\u201391. https:\/\/doi.org\/10.2337\/diacare.27.7.1688","journal-title":"Diabetes Care"},{"key":"7683_CR37","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.hlife.2023.06.001","volume":"1","author":"J Wang","year":"2023","unstructured":"Wang J. A roadmap for exploring the untouched protein space for biology and medicine. hLife. 2023;1:93\u20137. https:\/\/doi.org\/10.1016\/j.hlife.2023.06.001","journal-title":"hLife"},{"key":"7683_CR38","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2337\/db19-0942","volume":"69","author":"MR Shapiro","year":"2020","unstructured":"Shapiro MR, Wasserfall CH, McGrail SM, et al. Insulin-like growth factor dysregulation both preceding and following type 1 diabetes diagnosis. Diabetes. 2020;69:413\u201323. https:\/\/doi.org\/10.2337\/db19-0942","journal-title":"Diabetes"},{"key":"7683_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1530\/eje-22-0034","volume":"187","author":"NMT Meyer","year":"2022","unstructured":"Meyer NMT, Kabisch S, Dambeck U, et al. Low IGF1 and high IGFBP1 predict diabetes onset in prediabetic patients. Eur J Endocrinol. 2022;187:555\u201365. https:\/\/doi.org\/10.1530\/eje-22-0034","journal-title":"Eur J Endocrinol"},{"key":"7683_CR40","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/s12276-023-01019-8","volume":"55","author":"EH Choi","year":"2023","unstructured":"Choi EH, Park SJ. TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target. Exp Mol Med. 2023;55:1348\u201356. https:\/\/doi.org\/10.1038\/s12276-023-01019-8","journal-title":"Exp Mol Med"},{"key":"7683_CR41","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41467-022-28826-3","volume":"13","author":"G Xu","year":"2022","unstructured":"Xu G, Grimes TD, Grayson TB, et al. Exploratory study reveals far reaching systemic and cellular effects of verapamil treatment in subjects with type 1 diabetes. Nat Commun. 2022;13:1159. https:\/\/doi.org\/10.1038\/s41467-022-28826-3","journal-title":"Nat Commun"},{"key":"7683_CR42","doi-asserted-by":"publisher","first-page":"110179","DOI":"10.1016\/j.celrep.2021.110179","volume":"38","author":"S Yan","year":"2022","unstructured":"Yan S, Conley JM, Reilly AM, et al. Intestinal Gpr17 deficiency improves glucose metabolism by promoting GLP-1 secretion. Cell Rep. 2022;38:110179. https:\/\/doi.org\/10.1016\/j.celrep.2021.110179","journal-title":"Cell Rep"},{"key":"7683_CR43","doi-asserted-by":"publisher","first-page":"102445","DOI":"10.1016\/j.eclinm.2024.102445","volume":"68","author":"J Kim","year":"2024","unstructured":"Kim J, Yang HL, Kim SH, et al. Deep learning-based long-term risk evaluation of incident type 2 diabetes using electrocardiogram in a non-diabetic population: a retrospective, multicentre study. EClinicalMedicine. 2024;68:102445. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102445","journal-title":"EClinicalMedicine"},{"key":"7683_CR44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.1137","author":"CC Thomas","year":"2024","unstructured":"Thomas CC, Chopra K, Davis AM. Management of outpatients with diabetes at high risk of hypoglycemia. JAMA. 2024. https:\/\/doi.org\/10.1001\/jama.2024.1137","journal-title":"JAMA"},{"key":"7683_CR45","doi-asserted-by":"publisher","first-page":"e3610","DOI":"10.1002\/dmrr.3610","volume":"39","author":"MD G\u00f3mez-Guijarro","year":"2023","unstructured":"G\u00f3mez-Guijarro MD, \u00c1lvarez-Bueno C, Saz-Lara A, Sequ\u00ed-Dom\u00ednguez I, Lucer\u00f3n-Lucas-Torres M, Cavero-Redondo I. Association between severe hypoglycaemia and risk of dementia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2023;39:e3610. https:\/\/doi.org\/10.1002\/dmrr.3610","journal-title":"Diabetes Metab Res Rev"},{"key":"7683_CR46","doi-asserted-by":"publisher","first-page":"e075681","DOI":"10.1136\/bmj-2023-075681","volume":"384","author":"S Subramanian","year":"2024","unstructured":"Subramanian S, Khan F, Hirsch IB. New advances in type 1 diabetes. BMJ. 2024;384:e075681. https:\/\/doi.org\/10.1136\/bmj-2023-075681","journal-title":"BMJ"},{"key":"7683_CR47","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.4239\/wjd.v14.i9.1334","volume":"14","author":"KI Papadopoulos","year":"2023","unstructured":"Papadopoulos KI, Papadopoulou A, Aw TC. MicroRNA-155 mediates endogenous angiotensin II type 1 receptor regulation: implications for innovative type 2 diabetes mellitus management. World J Diabetes. 2023;14:1334\u201340. https:\/\/doi.org\/10.4239\/wjd.v14.i9.1334","journal-title":"World J Diabetes"},{"key":"7683_CR48","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.jhep.2014.06.032","volume":"61","author":"MJ Park","year":"2014","unstructured":"Park MJ, Kim DI, Lim SK, et al. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1\u03b1 regulation in vitro and in vivo. J Hepatol. 2014;61:1151\u20137. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.032","journal-title":"J Hepatol"},{"key":"7683_CR49","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/s0140-6736(11)60886-6","volume":"378","author":"T Orban","year":"2011","unstructured":"Orban T, Bundy B, Becker DJ, et al. Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. Lancet. 2011;378:412\u20139. https:\/\/doi.org\/10.1016\/s0140-6736(11)60886-6","journal-title":"Lancet"},{"key":"7683_CR50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.2337\/dc22-0908","volume":"46","author":"MR Rigby","year":"2023","unstructured":"Rigby MR, Hayes B, Li Y, Vercruysse F, Hedrick JA, Quattrin T. Two-year follow-up from the T1GER study: continued off-therapy metabolic improvements in children and young adults with new-onset T1D treated with golimumab and characterization of responders. Diabetes Care. 2023;46:561\u20139. https:\/\/doi.org\/10.2337\/dc22-0908","journal-title":"Diabetes Care"},{"key":"7683_CR51","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","volume":"361","author":"MD Pescovitz","year":"2009","unstructured":"Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, et al. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med. 2009;361:2143\u201352. https:\/\/doi.org\/10.1056\/NEJMoa0904452","journal-title":"N Engl J Med"},{"key":"7683_CR52","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/med4.75","volume":"2","author":"H Yuan","year":"2024","unstructured":"Yuan H, Yu K, Xie F, Liu M, Sun S. Automated machine learning with interpretation: a systematic review of methodologies and applications in healthcare. Med Adv. 2024;2:205\u201337. https:\/\/doi.org\/10.1002\/med4.75","journal-title":"Med Adv"},{"key":"7683_CR53","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2020.07.002","volume":"32","author":"LA Thielen","year":"2020","unstructured":"Thielen LA, Chen J, Jing G, et al. Identification of an anti-diabetic, orally available small molecule that regulates TXNIP expression and glucagon action. Cell Metab. 2020;32:353-65.e8. https:\/\/doi.org\/10.1016\/j.cmet.2020.07.002","journal-title":"Cell Metab"},{"key":"7683_CR54","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/aps.2017.15","volume":"38","author":"T Li","year":"2017","unstructured":"Li T, Lin GY, Zhong L, et al. W2476 ameliorates \u03b2-cell dysfunction and exerts therapeutic effects in mouse models of diabetes via modulation of the thioredoxin-interacting protein signaling pathway. Acta Pharmacol Sin. 2017;38:1024\u201337. https:\/\/doi.org\/10.1038\/aps.2017.15","journal-title":"Acta Pharmacol Sin"},{"key":"7683_CR55","doi-asserted-by":"publisher","first-page":"117887","DOI":"10.1016\/j.lfs.2020.117887","volume":"256","author":"FM Amin","year":"2020","unstructured":"Amin FM, Abdelaziz RR, Hamed MF, Nader MA, Shehatou GSG. Dimethyl fumarate ameliorates diabetes-associated vascular complications through ROS-TXNIP-NLRP3 inflammasome pathway. Life Sci. 2020;256:117887. https:\/\/doi.org\/10.1016\/j.lfs.2020.117887","journal-title":"Life Sci"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07683-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-025-07683-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07683-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:58:53Z","timestamp":1770202733000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-025-07683-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7683"],"URL":"https:\/\/doi.org\/10.1007\/s10557-025-07683-4","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"4 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}